Clinical Trial Update: Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)

View source ↗

Summary

This update outlines an ongoing clinical trial initiative in hepatocellular carcinoma focused on identifying tumor antigens to support innovative cancer immunot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Hepatocellular Carcinoma | Status: RECRUITING